Long-term effects of caffeine therapy for apnea of prematurity.

By B. Schmidt, R. Roberts, P. Davis, L. Doyle, K. Barrington, A. Ohlsson, A. Solimano, W. Tin. New England Journal of Medicine, 2007

882 citations recorded by the source corpus.

Subfields: Endocrine and Autonomic Systems, Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/7e94dcfbbb06196f5399c33204f729ad02359f16

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. B. Thébaud
2. R. Higgins
3. A. Jobe
4. M. Koso-Thomas
5. E. Bancalari
6. S. Davis
7. Camilia R. Martin
8. G. Konduri

Citations in the corpus

• Bronchopulmonary Dysplasia: Executive Summary of a Workshop (2018, background): “Caffeine used for apnea of prematurity or before extubation (median age of 3 days at initiation) was associated with decreased BPD,(36) and improved death or disability at 18-21 months of age.(37) At 5 years of age,(38) neonatal caffeine administration was no longer associated with an improved rate ”